John Sharp presented on building consumer-facing health devices and apps. He discussed key points like developing solutions that solve problems, understanding the market, prototyping and piloting before adopting and scaling, understanding the regulatory pathway, the importance of evidence, integrating data, and changing health behaviors. He also provided information on partnering with health systems, getting products to scale, involving patients in co-design, the FDA's digital health precertification program, developing digital evidence, and standards for data integration like FHIR and Continua Design Guidelines.
Building Consumer-Facing Health Devices and Apps and Doing it RightKent State University
For the HIMSS Delaware Valley Chapter. solve a problem; prototype, pilot, adopt and scale. FDA regulations, evidence, health behavior change, data integration
Personal connected health is currently characterized by limited thought leadership, insufficient coordination and collaboration, and a lack of awareness and understanding of the full potential by all stakeholders: public, providers, policymakers, industry and patients. The Personal Connected Health Alliance is defining the the field of personal connected health to inspire market and policy innovation, research and collective action for sustained adoption of personal connected health technology. The vision is better health and well being for all through increased personal responsibilities and connectivity as well as improved care delivery enabled by technology.
mHealth Israel_Future of Integrated Individualized Healthcare_Roche DiagnosticsLevi Shapiro
Presentation by Alexandra Eberhard, Sr. Director, Global Business Development, Roche Diagnostics on the "Future of Integrated Individualized Healthcare". Includes background about Roche Diagnostics and investments in innovation. Overview of Roche products and solutions with a portfolio covering the entire spectrum of diagnostics users. Emphasis on the triple aim of healthcare- The power of data and technology to enable the transformation from volume- to value-based healthcare. Interest in data for Pharma - drive more efficient R&D; DIA - develop novel patient care Dx solutions. Focus on the needs of labs, physicians & payers for better patient health. A suite of digital solutions that improve clinical & business outcomes. Suite of solutions to optimize the lab. Translating data into insights to achieve financial goals. A move from volume- to value-based care. New opportunities in the disease continuum- Holistic solutions approach. Expanding the focus towards earlier in the patient journey. Doing now what patients need next. Contact Alexandra Vallon-Eberhard, PhD MBA; Sr. Director Global Business Development; Diagnostics Lead for Innovation in Israel; Based in Basel, Switzerland; Email: alexandra.vallon_eberhard@roche.com
This is a 20-minute lecture covering points to consider when building value proposition unique to medical technology. It begins with a brief review of issues related to market adoption for medical technology and the hurdles that a medical technology innovator may encounter when taking a product to market. You will learn about the 7 key factors that would boost market fit.
http://semoegy.com
Building Consumer-Facing Health Devices and Apps and Doing it RightKent State University
For the HIMSS Delaware Valley Chapter. solve a problem; prototype, pilot, adopt and scale. FDA regulations, evidence, health behavior change, data integration
Personal connected health is currently characterized by limited thought leadership, insufficient coordination and collaboration, and a lack of awareness and understanding of the full potential by all stakeholders: public, providers, policymakers, industry and patients. The Personal Connected Health Alliance is defining the the field of personal connected health to inspire market and policy innovation, research and collective action for sustained adoption of personal connected health technology. The vision is better health and well being for all through increased personal responsibilities and connectivity as well as improved care delivery enabled by technology.
mHealth Israel_Future of Integrated Individualized Healthcare_Roche DiagnosticsLevi Shapiro
Presentation by Alexandra Eberhard, Sr. Director, Global Business Development, Roche Diagnostics on the "Future of Integrated Individualized Healthcare". Includes background about Roche Diagnostics and investments in innovation. Overview of Roche products and solutions with a portfolio covering the entire spectrum of diagnostics users. Emphasis on the triple aim of healthcare- The power of data and technology to enable the transformation from volume- to value-based healthcare. Interest in data for Pharma - drive more efficient R&D; DIA - develop novel patient care Dx solutions. Focus on the needs of labs, physicians & payers for better patient health. A suite of digital solutions that improve clinical & business outcomes. Suite of solutions to optimize the lab. Translating data into insights to achieve financial goals. A move from volume- to value-based care. New opportunities in the disease continuum- Holistic solutions approach. Expanding the focus towards earlier in the patient journey. Doing now what patients need next. Contact Alexandra Vallon-Eberhard, PhD MBA; Sr. Director Global Business Development; Diagnostics Lead for Innovation in Israel; Based in Basel, Switzerland; Email: alexandra.vallon_eberhard@roche.com
This is a 20-minute lecture covering points to consider when building value proposition unique to medical technology. It begins with a brief review of issues related to market adoption for medical technology and the hurdles that a medical technology innovator may encounter when taking a product to market. You will learn about the 7 key factors that would boost market fit.
http://semoegy.com
HXR 2017: Bakul Patel: How the FDA Is Promoting Innovation and Protecting the...HxRefactored
Health care entrepreneurs have described the FDA as a barrier to the market. Most of the time companies do not know when the FDA is regulating their app, device, or software. With new hands-off policies instituted to promote innovations to the market, Bakul will provide insights on the FDA's plans to regulating health technology as well as protecting the patients who are using the products.
These slides use concepts from my (Jeff Funk) course entitled Biz Models for Hi-Tech Products to analyze the business model for Oscar Health Insurance. Unlike most health care insurance companies, Oscar focuses on end-users as opposed to companies. It connects end users with its network of health care providers (e.g., doctors, hospitals). It focuses on end-users, largely because America’s new health care plan, usually called Obamacare, opened up this opportunity for focusing on end-users, who didn’t have coverage through employers. Oscar reduces its costs through a simpler form of web-based billing, Telemedicine, and wearable technology. These slides describe the value proposition, customers, method of value capture, scope of activities and the method of strategic control for Oscar.
AcuMedical was formed with the purpose of designing, developing, and promoting a minimally-invasive, integrated suite of medical devices that help patients and healthcare professionals effectively manage a variety of chronic or acute pain conditions through electro-stimulation.
It is crucial to highlight the atrocities occurring within the pain management industry. More specifically, prescription opioid-based painkillers, whose crippling side effects have now led to the White House declaring an official “public health emergency” in the United States. The rise of opioids to the forefront of the healthcare system has not only led to exponentially increasing overdose and hospitalization cases but also encourages illegal drug distribution to a growing population of victims.
Electro-stimulation and needle therapy procedures are well-known for their safety and effectiveness in treating chronic and acute pain. They are recommended by the FDA as a non-pharma therapy and useful in opiate rehab. AcuMedical has developed patent-pending technologies that introduce a procedure-based, digital electro-needle therapy platform that collects data qualified toward reliable insurance reimbursement and streamlines the therapy making patient treatment safer, consistent, and more effective.
With the global market for pain management devices totaling more than $3.2Bn in 2016 within the growing $60Bn global pain management therapeutics market, our products are positioned to gain prominence and compete within the exponentially expanding $130Bn traditional Chinese medicine market in China post-internationalization.
Clinical Biometrics, Inc. Executive Overview
Description Clinical Biometrics is an organization dedicated to enabling predictive healthcare and disease prevention with the IoT. We are working on the IoT (Internet of Things) wireless, biomedical patient monitoring and vendor agnostic integration, pioneering programmable biosensors, integration products and services to monitor secure clinical data in real-time and over time, for inpatient and outpatient environments. Our model enables predictive and preventative healthcare delivery. We are developing vendor agnostic middleware that will allow the integration of the various vendor's sensors and protocols into a common platform with rich data analytics capabilities. This technology will impact our healthcare paradigms and usher us into the future of healthcare delivery including real-time predictive healthcare and disease prevention.
- Tim Crammer, CEO
New digital practices of health professionalsVirtualExpo
How health professionals search for information
Being a health professional today is far
different from what it used to be. This
observation might seem simple, but it
actually implies a lot. Not only have the
tools, methods and software changed,
but the advent of digital technology
has revolutionized looking for information
and keeping up-to-date.
This is why we decided to ask health
professionals how these changes affect
their daily lives and how they integrate
the new methods into their practices.
United States Diagnostics Market Size, Share, Trend and Forecast 2026 | TechS...TechSci Research
According to #TechSci Research report, United States Diagnostics Market stood at USD30.08billion in 2020 and is expected to grow at a steady rate of 5.17% during the forecast period.
Gain More Insight: https://bit.ly/3wWI0do
Get Sample Report: https://bit.ly/3ltFdo6
Website: https://www.techsciresearch.com/
Market Research News: https://techsciblog.com/
Driving risk management through intelligent intake technologyMyMeds&Me
MyMeds&Me CEO Dr. Andrew Rut presents the case for driving risk management through intelligent intake technology.
Andrew outlines how pharmacovigilance professionals can move from passive to active PV fuelling better decision-making.
This presentations covers:
Pharmacovigilance and risk management challenges
Evolving PV landscape
Addressing the challenges
Reviewing the possible architecture
A glimpse of the technology
Implementation benefits
For more info see: www.mymedsandme.com
The potential of a digital health ecosystemVelametis
Our idea of digital health ecosystems and their potential to deliver value to all stakeholders involved, is changing. The COVID-19 pandemic accelerated the need to improve remote care, engagement tools and interconnectivity, which are all necessary to support a functioning digital ecosystem.
In this opinion piece, we touch upon the basic components of a Digital Health Ecosystem and how it can be optimised with health technology.
Content overview:
What is a Digital Health Ecosystem?
Why Do We Need Digital Health Ecosystems?
The Pros and Cons
The Potential
Digital Health Ecosystems to Watch
Download here:
https://velametis.com/the-potential-of-a-digital-health-ecosystem/
More and more health economies across the globe are deploying Electronic Health Records with some countries reaching full adoption by 2017. This means we, as healthcare marketers, now have a vital new channel to reach and educate decision makers.
Managing an end to end Pharmacovigilance system from affiliates to regulatory...MyMeds&Me
MyMeds&Me CEO Dr. Andrew Rut explores how technology can help address the challenges facing Pharmacovigilance teams.
He reviews how the latest intake technology can influence end-user experience and effectiveness, as well as internal value & efficiency.
He concludes that a focus on simplifying case intake re-shapes the traditional PV system, enabling Pharma companies to reap significant process and efficiency benefits.
Creating Interoperable Medical Devices that fit into Hospital Enterprise IT E...Shahid Shah
Creating connected medical devices is challenging but doing so in an interoperable manner that can easily and flexibly fit into modern hospital IT environments is even more difficult. This presentation provides sage advice on how to design connected life-critical medical devices so that they work well within modern hospital environments.
Building Consumer-Facing Health Devices and Apps and Doing it RightKent State University
Presentation to the Medical Capital Innovation Competition in Cleveland 4/23/18 including the regulatory pathway, importance of evidence and data integration.
HXR 2017: Bakul Patel: How the FDA Is Promoting Innovation and Protecting the...HxRefactored
Health care entrepreneurs have described the FDA as a barrier to the market. Most of the time companies do not know when the FDA is regulating their app, device, or software. With new hands-off policies instituted to promote innovations to the market, Bakul will provide insights on the FDA's plans to regulating health technology as well as protecting the patients who are using the products.
These slides use concepts from my (Jeff Funk) course entitled Biz Models for Hi-Tech Products to analyze the business model for Oscar Health Insurance. Unlike most health care insurance companies, Oscar focuses on end-users as opposed to companies. It connects end users with its network of health care providers (e.g., doctors, hospitals). It focuses on end-users, largely because America’s new health care plan, usually called Obamacare, opened up this opportunity for focusing on end-users, who didn’t have coverage through employers. Oscar reduces its costs through a simpler form of web-based billing, Telemedicine, and wearable technology. These slides describe the value proposition, customers, method of value capture, scope of activities and the method of strategic control for Oscar.
AcuMedical was formed with the purpose of designing, developing, and promoting a minimally-invasive, integrated suite of medical devices that help patients and healthcare professionals effectively manage a variety of chronic or acute pain conditions through electro-stimulation.
It is crucial to highlight the atrocities occurring within the pain management industry. More specifically, prescription opioid-based painkillers, whose crippling side effects have now led to the White House declaring an official “public health emergency” in the United States. The rise of opioids to the forefront of the healthcare system has not only led to exponentially increasing overdose and hospitalization cases but also encourages illegal drug distribution to a growing population of victims.
Electro-stimulation and needle therapy procedures are well-known for their safety and effectiveness in treating chronic and acute pain. They are recommended by the FDA as a non-pharma therapy and useful in opiate rehab. AcuMedical has developed patent-pending technologies that introduce a procedure-based, digital electro-needle therapy platform that collects data qualified toward reliable insurance reimbursement and streamlines the therapy making patient treatment safer, consistent, and more effective.
With the global market for pain management devices totaling more than $3.2Bn in 2016 within the growing $60Bn global pain management therapeutics market, our products are positioned to gain prominence and compete within the exponentially expanding $130Bn traditional Chinese medicine market in China post-internationalization.
Clinical Biometrics, Inc. Executive Overview
Description Clinical Biometrics is an organization dedicated to enabling predictive healthcare and disease prevention with the IoT. We are working on the IoT (Internet of Things) wireless, biomedical patient monitoring and vendor agnostic integration, pioneering programmable biosensors, integration products and services to monitor secure clinical data in real-time and over time, for inpatient and outpatient environments. Our model enables predictive and preventative healthcare delivery. We are developing vendor agnostic middleware that will allow the integration of the various vendor's sensors and protocols into a common platform with rich data analytics capabilities. This technology will impact our healthcare paradigms and usher us into the future of healthcare delivery including real-time predictive healthcare and disease prevention.
- Tim Crammer, CEO
New digital practices of health professionalsVirtualExpo
How health professionals search for information
Being a health professional today is far
different from what it used to be. This
observation might seem simple, but it
actually implies a lot. Not only have the
tools, methods and software changed,
but the advent of digital technology
has revolutionized looking for information
and keeping up-to-date.
This is why we decided to ask health
professionals how these changes affect
their daily lives and how they integrate
the new methods into their practices.
United States Diagnostics Market Size, Share, Trend and Forecast 2026 | TechS...TechSci Research
According to #TechSci Research report, United States Diagnostics Market stood at USD30.08billion in 2020 and is expected to grow at a steady rate of 5.17% during the forecast period.
Gain More Insight: https://bit.ly/3wWI0do
Get Sample Report: https://bit.ly/3ltFdo6
Website: https://www.techsciresearch.com/
Market Research News: https://techsciblog.com/
Driving risk management through intelligent intake technologyMyMeds&Me
MyMeds&Me CEO Dr. Andrew Rut presents the case for driving risk management through intelligent intake technology.
Andrew outlines how pharmacovigilance professionals can move from passive to active PV fuelling better decision-making.
This presentations covers:
Pharmacovigilance and risk management challenges
Evolving PV landscape
Addressing the challenges
Reviewing the possible architecture
A glimpse of the technology
Implementation benefits
For more info see: www.mymedsandme.com
The potential of a digital health ecosystemVelametis
Our idea of digital health ecosystems and their potential to deliver value to all stakeholders involved, is changing. The COVID-19 pandemic accelerated the need to improve remote care, engagement tools and interconnectivity, which are all necessary to support a functioning digital ecosystem.
In this opinion piece, we touch upon the basic components of a Digital Health Ecosystem and how it can be optimised with health technology.
Content overview:
What is a Digital Health Ecosystem?
Why Do We Need Digital Health Ecosystems?
The Pros and Cons
The Potential
Digital Health Ecosystems to Watch
Download here:
https://velametis.com/the-potential-of-a-digital-health-ecosystem/
More and more health economies across the globe are deploying Electronic Health Records with some countries reaching full adoption by 2017. This means we, as healthcare marketers, now have a vital new channel to reach and educate decision makers.
Managing an end to end Pharmacovigilance system from affiliates to regulatory...MyMeds&Me
MyMeds&Me CEO Dr. Andrew Rut explores how technology can help address the challenges facing Pharmacovigilance teams.
He reviews how the latest intake technology can influence end-user experience and effectiveness, as well as internal value & efficiency.
He concludes that a focus on simplifying case intake re-shapes the traditional PV system, enabling Pharma companies to reap significant process and efficiency benefits.
Creating Interoperable Medical Devices that fit into Hospital Enterprise IT E...Shahid Shah
Creating connected medical devices is challenging but doing so in an interoperable manner that can easily and flexibly fit into modern hospital IT environments is even more difficult. This presentation provides sage advice on how to design connected life-critical medical devices so that they work well within modern hospital environments.
Building Consumer-Facing Health Devices and Apps and Doing it RightKent State University
Presentation to the Medical Capital Innovation Competition in Cleveland 4/23/18 including the regulatory pathway, importance of evidence and data integration.
The Foundations of Success in Population Health ManagementHealth Catalyst
From hospital systems to large employers, organizations are increasingly taking on financial risk for the health of populations. Drivers of this trend include the update to the MSSP model, the recent CMS Primary Cares Initiative announcement, the increasing prevalence of the Medicare Advantage model, innovative partnerships in the self-insured employer space, and the proliferation of Medicaid ACOs. Yet while market pressures push organizations toward population risk, they don't necessarily help them succeed: most organizations are struggling to attain or sustain the dual imperatives of high-quality care and cost containment. A primary reason? Short-sighted and tactical approaches that don't provide the flexible data infrastructure and tools to adapt to emerging trends in population health—or to support short-term contractual requirements while building toward long-term success.
View this launch webinar to learn about Health Catalyst’s Population Health Foundations solution, a data and analytics-first starter set aimed at optimizing performance in value-based risk arrangements and providing the data ecosystem that will flex and adapt to complex needs of risk-bearing organizations. Solution services ensure that the strategic value of data is maximized to improve performance in risk contracts—and provide side-by-side subject matter expert partnership for establishing short- and long-term goals for population health management (PHM).
Built on Health Catalyst’s foundational technology and supported by the nationwide experience and perspective of its experts, the Population Health Foundations solution helps organizations leverage multiple data sources to understand their patient populations and create meaningful views of financial and clinical quality performance. As a starter set that organizations can build on based on their needs, the solution is designed to compensate for the known limitations of “black box” population health applications that fail to reveal the “why” of analytic insights and exacerbate the challenges of transforming quality, cost, and care. The Population Health Foundations solution delivers the essential analytic tools needed for success under value-based risk arrangements.
In these slides you can expect to:
- Review recent changes to the field of value-based care, and reactions and insights from the market
- Discover how the Population Health Foundations solution can act as a comprehensive, data-first analytics solution to support your population stratification and monitoring needs
- Understand how this solution functions as a foundational starter set for value-based care success, enabling clients to leverage all their data and other relevant population health tools
Overcoming Cloud-Based Mobility Challenges in HealthcareAnyPresence
April Sage of Online Tech and Rich Mendis of AnyPresence review the common challenges associated with mobile enablement, and introduced the new technologies that are empowering healthcare providers to securely engage their patients and practitioners through the mobile channel.
2016 IBM Interconnect - medical devices transformationElizabeth Koumpan
Emerging technologies such as Internet of Things, 3D Printing are driving the creation of new business models and forcing the Industry for transformation. The product centric model where the Industry main objective was to develop the device, is moving to software and services model, with the focus on Big Data & Analytics, Integration and Cloud.
The maturation of technologies such as social, mobile, analytics, cloud, 3D printing, bio- and nanotechnology are rapidly shifting the competitive landscape. These emerging technologies create an environment that is connected and open, simple and intelligent, fast and scalable. Organizations must embrace disruptive technologies to drive innovation
A summary of macro level trends and issues that are driving the need for enhanced digital marketing and service delivery in the Pharma/Healthcare industry. Included are case studies presented at the recent ePharm Summit in NYC.
Empowering Healthcare: The Evolution of Healthcare App Development ServicesElina619459
In today's digital age, healthcare is no longer limited to traditional brick-and-mortar clinics and hospitals. The advent of healthcare app development services has ushered in a new era of accessible, efficient, and patient-centric healthcare solutions. These applications have transformed the way patients interact with healthcare providers, manage their health, and access vital medical information.
Implications for risk management of digital health technologiesDavid Lee Scher, MD
Digital health technology is becoming a critical part of healthcare. As tools used in care (directly and indirectly), it has implications with regards to risk management. These are discussed from both liability and mitigation perspectives.
Open Source is a great opportunity for EHR, Digital Health, and Health IT Int...Shahid Shah
Presented at the OSEHRA Summit 2014, this talk focused on:
* OSEHRA is major business opportunity for ISVs and systems integrators
* Open source software and associated business models can satisfy most needs.
* There’s nothing special about health IT data that justifies complex, expensive, or special technology.
Opening Keynote: The Convergence of mHealth: A Consumer and Clinical Perspective
Description: In the opening keynote attendees will hear an overview from a current HIMSS mHealth Community Member which sets the stage for discussion. The keynote will highlight facts and figures which support the thesis of increased utilization of mobile and wireless technologies by healthcare providers. The keynote will also set the stage with current issues impacting the continued adoption.
Speaker(s): Ahmed Albaiti
Objectives: Assess the current landscape of mHealth. Illustrate the roles of consumers and patients. Define the current issues.
The healthcare industry is making significant advancements with a patient-centric approach to healthcare app development. Find out more.
Read: https://www.peppersquare.com/blog/an-all-inclusive-guide-on-how-to-develop-a-stellar-healthcare-app/
The FDA Digital Health Center of Excellence and the Advancement of Digital He...Greenlight Guru
The FDA Digital Health Center of Excellence is part of the planned evolution of the digital health program with the intent to drive synergy for digital health efforts, align strategy with implementation, prepare the FDA for the digital health future, and protect patients and maintain the FDA standards of safety and effectiveness.
Ultimately, the program works to strategically advance science and evidence for digital health technologies that meets the needs of
stakeholders.
This free in-depth webinar, presented by Matthew DiamondChief Medical Officer, Digital Health Center of Excellence, will cover the digital health landscape and areas of application, goals and outcomes, planned services and launch plan, and the current areas of focus - including AI/ML-Based SaMD.
This presentation originally aired during the 2021 State of Medical Device Virtual Summit.
با گسترش فناوری اطلاعات و سرویس های مختلفی امروزه در زندگی انسان ها ارائه می شود حوزه سلامت و درمان هم بی بهره از این گسترش فناوری نبوده و در صورتی که سیاستمداران و برنامه ریزان کشور بتوانند از ظرفیت های ترکیب دانش پزشکی و فناوری اطلاعات بهره ببرند شاید با وجود افزایش جمعیت کهنسال و نیاز به رسیدگی های خاصی که در این قشر احساس می شود بتوان در کاهش هزینه های درمان گامی برداشت
Similar to Building Consumer-Facing Health Devices and Apps and Doing it Right (20)
To make remote monitoring devices interoperable, we must examine a variety of use cases and the current evidence of their effectiveness. The presentation is from the January 2020 IHE Connectathon in Cleveland, Oho.
How Interconnectivity Is Enabling The Future Of Patient-Driven HealthKent State University
Connected health and remote patient monitoring, combined with interactive patient engagement apps, have a tremendous potential to transform chronic disease management for patients to manage at home allowing them to live their lives with independence. But deploying such programs, and managing the IoT assets they often depend on, can pose a host of challenges at both the provider and the patient level.
With @Atreja at the NODE Health Conference - Digital Medicine http://digitalmedicineconference.com/ on the events and studies which moved the field forward
PCHAlliance conducted a systematic review of published literature to gather the available data on health outcome measures, reviewing over 1,450 citations. Fifty-three randomized controlled studies and trials were selected for analysis, on topics related to mobile technologies, remote patient monitoring, web-based counseling and other personal connected health technologies. This publication aims to set an initial baseline for the current body of evidence in personal connected health in key areas, namely behavior change and self-care, remote patient monitoring, remote counseling and mental health, as well as more broadly through key condition-specific studies.
Download the paper here: http://www.pchalliance.org/personal-connected-health-state-evidence-and-call-action
Patient Engagement is more that an patient portal
Connected Health tools are available to enhance engagement
Personalization is needed to engage
How patient engagement technologies fit with population health
Helping those lacking health and digital literacy and access
The future is bright for Personal Connected Health
The Internet of Things (IoT) is the latest buzzword out of the interface between information technology and business. As technologies like Bluetooth and sensors enable connections between devices and networks, innovation has brought connections between devices and a human interface. In healthcare, this has been termed the Internet of Medical Things or Healthy things. Medical devices and consumer health devices generate data which can be analyzed, synthesized and displayed for the consumer and healthcare provider to get a broader picture of one’s health. Everything from fitness devices to glucose monitors can give us information about our current health status as never before. How this will integrate into a clinician’s workflow is a new journey of discovery as medical practice catches up with these innovations.
Registries are a powerful informatics tool for research and public health. As both commercial payers and the Centers for Medicare and Medicaid Services work to shift incentives shift toward value based-purchasing, demand for reliable, accessible data on populations is growing. The purpose of this poster is to define accountable care organizations (ACOs), explain the importance of registries in managing data for ACOs, and discuss specific informatics requirements unique to accountable care registries.
The HIMSS Connected Health Conference took place on November 8-11, 2015 at the National Harbor in Washington, DC. It included Mobile Health, Cybersecurity and Population Health topics.
My presentation to the Personalized Medicine meet of the American Cancer Society Cancer Action Network on August 11, 2015 at the HIMSS Innovation Center in Cleveland, Ohio.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Surgical Site Infections, pathophysiology, and prevention.pptx
Building Consumer-Facing Health Devices and Apps and Doing it Right
1. Building Consumer-Facing Health Devices and Apps
and Doing it Right
HIMSS Northern Ohio Chapter 5/23/19
John Sharp, Director @PCHAlliance
2. 2
Personal Connected Health Alliance
Help people make health and wellness an effortless part of daily life
• Focused on consumer-facing health technology
• More than 80 corporate members
• Key initiatives: digital therapeutics, behavior change, aging and tech
and innovation
• Connected Health Conference – October 16-18, 2018, Boston
• A HIMSS Innovation Company
3. 3
My experience
• HIMSS staff since 2013
• Previously at the Cleveland Clinic
in Clinical Research Informatics
• Advisor for Healthbox and the Medical Capital Innovation
Competition
• Adjunct Professor, Health Informatics, Kent State University
4. 4
Key Points Today
• Developing an app or device which solves a problem
• Which integrates into clinical workflow or consumer’s lifestyle
• Understand the market
• Prototype, Pilot, Adopt, Scale
• Understand the regulatory pathway
• Importance of Evidence
• Changing Health Behaviors
• Data integration
9. 9
Understanding the Market
• Telehealth is the largest growth area
• Remote monitoring still a small percentage (3% by one report) but may grow as
payment models change including share risk
• Virtual coaching is hitting its pace – virtual physical/occupational therapy
including VR, Diabetes Prevention Programs, chronic disease management
• Employee wellness using wearables is scaling – Walmart app for employees,
Aetna/Apple partnership, payers and employers partnering with Fitbit
13. 13
Partnering with Health Systems
Good news – many have innovation centers as a point of entry
Find a physician or administrator as a champion
Not your typical funding pitch
Do they have the problem you are trying to fix?
Does it save time for physicians?
Is there a potential ROI? Does it take cost/complexity out of the system?
Does it integrate with their EMR or other key systems?
14. 14
Getting to Scale
• Right partners
• Technology that scales
• Wearable production
• Managing thousands of users
• Business model
• Appropriate funding
• Turn Solutions into Strategy
• Potential exit
See Can We Achieve Scale in Innovation? – NEJM Catalyst 2017
15. 15
Involving Patients in Co-Design
In all stages of designing consumer-facing apps and devices
Partnerships with:
• WEGO Health
• Savvy Coop
• Society of Participatory Medicine
16. 16
Now part of the HIMSS family
Innovation consulting
Fund management/Strategic Investing
Commercialization Analysis
Headquartered in Chicago
18. 18
Clinical Apps and Devices
Software as a Medical Device (SaMD) – now defined by the FDA
software intended to be used for one or more medical purposes that perform
these purposes without being part of a hardware medical device
SaMD may be interfaced with other medical devices, including hardware medical
devices and other SaMD software, as well as general purpose software
Mobile apps that meet the definition above are considered SaMD
19. 19
Software as a Medical Device –
Examples
• diagnosis, prevention, monitoring, treatment or alleviation of disease
or injury
• provide means and suggestions for mitigation of a disease
(clinical decision support)
• be an aid to diagnosis, screening, monitoring, determination of
predisposition; prognosis, prediction, determination of physiological
status.
22. 22
Who Is Currently Involved in the Pre-Cert Pilot
Program?
• Phosphorus
• Roche
• Samsung
• Tidepool
• Verily
•Apple
•Fitbit
•Johnson & Johnson
•Pear Therapeutics
23. 23
When to Conduct a Study and IRB
Type of Study Conduct a study? Need IRB review?
Clinical efficiency Yes, validation No
Clinical Decision Support Yes Yes, since it directly impacts
patient care
Patient Education Maybe Apply for an exemption from
the IRB
Wellness device Yes, validation and
outcomes
Probably not
Medical device used for remote monitoring Yes, validation and
outcomes
Yes
Mobile app to manage a chronic condition Yes, validation and
outcomes
Yes
Mobile device to manage a chronic condition Yes, validation and
outcomes
Yes, may also be subject to
FDA review
IoT or supply chain Some validation No
27. 27
Network of Digital Evidence
Combine the rigor of Evidence Based Medicine (EBM) with
emerging healthcare technologies to help create
evidence-based digital medicine
More than 40 health systems participating
Monthly newsletter
www.nodehealth.org
New article on Clinical Validation in Digital Biomarkers
28. 28
The Challenge of Health Behavior Change
The experts - Society of Behavioral Medicine
A multidisciplinary organization of clinicians, educators, and scientists
dedicated to
• promoting the study of the interactions of behavior with biology and the
environment
• then applying that knowledge to improve the health and well-being of
individuals, families, communities, and populations.
• From medication adherence to weight loss to smoking cessation and
more…
• www.sbm.org
30. 30
Continua Design Guidelines
Open source development model – the Continua Design Guidelines are
universally accessible, non-proprietary and not for profit
Flexibility – designed to provide maximum choice for developers and end users
(healthcare buyers, individual clinicians and consumers)
Using FHIR standard
http://www.pchalliance.org/continua-design-guidelines
31. 31
Apple Health Kit
As an EHR and app integration tool.
When a customer provides permission for your app to read and write health and
activity data to their Health app, your app can become a valuable health data
source.
Also uses FHIR
Instructions for how to integrate with Apple Watch
https://developer.apple.com/healthkit/
32. 32
Fast Healthcare Interoperability Resource
Exchangeable content is defined as a resource
• A common way to define and represent them, building them from data
types that define common reusable patterns of elements
• A common set of metadata
• A human readable part
Uses RESTful Web services
Enables integration of Patient Generated Health Data
33. 33
What’s Next?
Technology uses yet to be
discovered
More functions for
wearables
Implantables, ingestibles
Apps for more conditions
Digital Health Platforms
Broader application of
VR/AR
New business models
More evidence including on
health behavior change
More customer convenience
Broader partnerships
Leading to Digital transformation
34. 34
Key Points Today
• Developing an app or device which solves a problem
• Which integrates into clinical workflow or consumer’s lifestyle
• Understand the market
• Prototype, Pilot, Adopt, Scale
• Understand the regulatory pathway
• Importance of Evidence
• Data integration